- Home
- TRVG vs HRTX Comparison
TRVG vs HRTX Comparison
Compare TRVG & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVG
- HRTX
- Stock Information
- Founded
- TRVG 2005
- HRTX 1983
- Country
- TRVG Germany
- HRTX United States
- Employees
- TRVG N/A
- HRTX N/A
- Industry
- TRVG EDP Services
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- TRVG Technology
- HRTX Health Care
- Exchange
- TRVG Nasdaq
- HRTX Nasdaq
- Market Cap
- TRVG 306.5M
- HRTX 325.0M
- IPO Year
- TRVG N/A
- HRTX 1987
- Fundamental
- Price
- TRVG $4.14
- HRTX $1.93
- Analyst Decision
- TRVG Buy
- HRTX Strong Buy
- Analyst Count
- TRVG 4
- HRTX 2
- Target Price
- TRVG $4.88
- HRTX $5.50
- AVG Volume (30 Days)
- TRVG 138.1K
- HRTX 2.1M
- Earning Date
- TRVG 07-29-2025
- HRTX 05-06-2025
- Dividend Yield
- TRVG N/A
- HRTX N/A
- EPS Growth
- TRVG N/A
- HRTX N/A
- EPS
- TRVG N/A
- HRTX N/A
- Revenue
- TRVG $522,618,892.00
- HRTX $148,518,000.00
- Revenue This Year
- TRVG $13.01
- HRTX $12.60
- Revenue Next Year
- TRVG $7.04
- HRTX $13.66
- P/E Ratio
- TRVG N/A
- HRTX N/A
- Revenue Growth
- TRVG 1.70
- HRTX 12.43
- 52 Week Low
- TRVG $1.60
- HRTX $1.04
- 52 Week High
- TRVG $5.83
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- TRVG 43.90
- HRTX 45.93
- Support Level
- TRVG $3.99
- HRTX $1.82
- Resistance Level
- TRVG $4.65
- HRTX $1.93
- Average True Range (ATR)
- TRVG 0.26
- HRTX 0.11
- MACD
- TRVG -0.08
- HRTX -0.00
- Stochastic Oscillator
- TRVG 11.39
- HRTX 56.76
About TRVG trivago N.V.
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.